The Asia Pacific Dental Bone Grafts And Substitutes Market should witness market growth of 8.8% CAGR during the forecast period (2022-2028).
A bone grafting operation enlarges a patient's jawline, which is crucial since a weak jawbone undermines dental health. The jawbone is what maintains the teeth in their proper positions. If a patient wants one or more dental implants put in their mouth, there must be enough jawbone for the implant(s) to be held firmly in place. This also applies to those who need traditional dentures.
An allograft derivative known as demineralized bone matrix undergoes an acid treatment to dissolve the mineral mesh. Due to the removal of the bone's antigenic surface structure after acid treatment, the demineralized bone matrix is generally simple to work with and exhibits the typical advantages of allograft material.
There are more highly trained dental surgeons in the Asia-Pacific area. The number of people travelling for medical treatment has grown as a result. With a sizable number of dental hospitals and dental laboratories, the country has developed into a centre for dental healthcare. Due to the abundance of qualified dentists, cheap care, cutting-edge technology, a variety of travel destinations around the nation, visa on arrival for several countries, and accessible transportation options & high-quality lodging, dental tourism is on the rise in India.
The China market dominated the Asia Pacific Dental Bone Grafts and Substitutes Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $84.2 million by 2028.The Japan market is estimated to grow a CAGR of 8.1% during (2022-2028). Additionally, The India market would experience a CAGR of 9.4% during (2022-2028).
Based on End-use, the market is segmented into Dental Clinics and Hospitals. Based on Material Type, the market is segmented into Xenograft, Allograft, Autograft and Synthetic. Based on Application, the market is segmented into Socket Preservation, Ridge Augmentation, Implant Bone Regeneration, Periodontal Defect Regeneration and Sinus Lift. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Zimmer Biomet Holdings, Inc., Dentsply Sirona, Inc., Stryker Corporation, Institut Straumann AG, BioHorizons, Inc. (Henry Schein, Inc.), RTI Surgical, Inc., Geistlich Pharma AG (The Geistlich Group), Collagen Matrix, Inc. (Linden Capital Partners), and Dentium Co., Ltd.
A bone grafting operation enlarges a patient's jawline, which is crucial since a weak jawbone undermines dental health. The jawbone is what maintains the teeth in their proper positions. If a patient wants one or more dental implants put in their mouth, there must be enough jawbone for the implant(s) to be held firmly in place. This also applies to those who need traditional dentures.
An allograft derivative known as demineralized bone matrix undergoes an acid treatment to dissolve the mineral mesh. Due to the removal of the bone's antigenic surface structure after acid treatment, the demineralized bone matrix is generally simple to work with and exhibits the typical advantages of allograft material.
There are more highly trained dental surgeons in the Asia-Pacific area. The number of people travelling for medical treatment has grown as a result. With a sizable number of dental hospitals and dental laboratories, the country has developed into a centre for dental healthcare. Due to the abundance of qualified dentists, cheap care, cutting-edge technology, a variety of travel destinations around the nation, visa on arrival for several countries, and accessible transportation options & high-quality lodging, dental tourism is on the rise in India.
The China market dominated the Asia Pacific Dental Bone Grafts and Substitutes Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $84.2 million by 2028.The Japan market is estimated to grow a CAGR of 8.1% during (2022-2028). Additionally, The India market would experience a CAGR of 9.4% during (2022-2028).
Based on End-use, the market is segmented into Dental Clinics and Hospitals. Based on Material Type, the market is segmented into Xenograft, Allograft, Autograft and Synthetic. Based on Application, the market is segmented into Socket Preservation, Ridge Augmentation, Implant Bone Regeneration, Periodontal Defect Regeneration and Sinus Lift. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Zimmer Biomet Holdings, Inc., Dentsply Sirona, Inc., Stryker Corporation, Institut Straumann AG, BioHorizons, Inc. (Henry Schein, Inc.), RTI Surgical, Inc., Geistlich Pharma AG (The Geistlich Group), Collagen Matrix, Inc. (Linden Capital Partners), and Dentium Co., Ltd.
Scope of the Study
By End-use
- Dental Clinics
- Hospitals
By Material Type
- Xenograft
- Allograft
- Autograft
- Synthetic
By Application
- Socket Preservation
- Ridge Augmentation
- Implant Bone Regeneration
- Periodontal Defect Regeneration
- Sinus Lift
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Zimmer Biomet Holdings, Inc.
- Dentsply Sirona, Inc.
- Stryker Corporation
- Institut Straumann AG
- BioHorizons, Inc. (Henry Schein, Inc.)
- RTI Surgical, Inc.
- Geistlich Pharma AG (The Geistlich Group)
- Collagen Matrix, Inc. (Linden Capital Partners)
- Dentium Co., Ltd.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Dental Bone Grafts and Substitutes Market, by End-use
1.4.2 Asia Pacific Dental Bone Grafts and Substitutes Market, by Material Type
1.4.3 Asia Pacific Dental Bone Grafts and Substitutes Market, by Application
1.4.4 Asia Pacific Dental Bone Grafts and Substitutes Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Asia Pacific Dental Bone Grafts and Substitutes Market by End-use
3.1 Asia Pacific Dental Clinics Market by Country
3.2 Asia Pacific Hospitals Market by Country
Chapter 4. Asia Pacific Dental Bone Grafts and Substitutes Market by Material Type
4.1 Asia Pacific Xenograft Market by Country
4.2 Asia Pacific Allograft Market by Country
4.3 Asia Pacific Autograft Market by Country
4.4 Asia Pacific Synthetic Market by Country
Chapter 5. Asia Pacific Dental Bone Grafts and Substitutes Market by Application
5.1 Asia Pacific Socket Preservation Market by Country
5.2 Asia Pacific Ridge Augmentation Market by Country
5.3 Asia Pacific Implant Bone Regeneration Market by Country
5.4 Asia Pacific Periodontal Defect Regeneration Market by Country
5.5 Asia Pacific Sinus Lift Market by Country
Chapter 6. Asia Pacific Dental Bone Grafts and Substitutes Market by Country
6.1 China Dental Bone Grafts and Substitutes Market
6.1.1 China Dental Bone Grafts and Substitutes Market by End-use
6.1.2 China Dental Bone Grafts and Substitutes Market by Material Type
6.1.3 China Dental Bone Grafts and Substitutes Market by Application
6.2 Japan Dental Bone Grafts and Substitutes Market
6.2.1 Japan Dental Bone Grafts and Substitutes Market by End-use
6.2.2 Japan Dental Bone Grafts and Substitutes Market by Material Type
6.2.3 Japan Dental Bone Grafts and Substitutes Market by Application
6.3 India Dental Bone Grafts and Substitutes Market
6.3.1 India Dental Bone Grafts and Substitutes Market by End-use
6.3.2 India Dental Bone Grafts and Substitutes Market by Material Type
6.3.3 India Dental Bone Grafts and Substitutes Market by Application
6.4 South Korea Dental Bone Grafts and Substitutes Market
6.4.1 South Korea Dental Bone Grafts and Substitutes Market by End-use
6.4.2 South Korea Dental Bone Grafts and Substitutes Market by Material Type
6.4.3 South Korea Dental Bone Grafts and Substitutes Market by Application
6.5 Singapore Dental Bone Grafts and Substitutes Market
6.5.1 Singapore Dental Bone Grafts and Substitutes Market by End-use
6.5.2 Singapore Dental Bone Grafts and Substitutes Market by Material Type
6.5.3 Singapore Dental Bone Grafts and Substitutes Market by Application
6.6 Malaysia Dental Bone Grafts and Substitutes Market
6.6.1 Malaysia Dental Bone Grafts and Substitutes Market by End-use
6.6.2 Malaysia Dental Bone Grafts and Substitutes Market by Material Type
6.6.3 Malaysia Dental Bone Grafts and Substitutes Market by Application
6.7 Rest of Asia Pacific Dental Bone Grafts and Substitutes Market
6.7.1 Rest of Asia Pacific Dental Bone Grafts and Substitutes Market by End-use
6.7.2 Rest of Asia Pacific Dental Bone Grafts and Substitutes Market by Material Type
6.7.3 Rest of Asia Pacific Dental Bone Grafts and Substitutes Market by Application
Chapter 7. Company Profiles
7.1 Medtronic PLC
7.1.1 Company overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expenses
7.1.5 Recent strategies and developments:
7.1.5.1 Product Launches and Product Expansions:
7.1.6 SWOT Analysis
7.2 Zimmer Biomet Holdings, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations and Agreements:
7.3 Dentsply Sirona, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional & Segmental Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent Strategies and Development:
7.3.5.1 Product launches and Product Expansions:
7.4 Stryker Corporation
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Institut Straumann AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.6 BioHorizons, Inc. (Henry Schein, Inc.)
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.7 RTI Surgical, Inc.
7.7.1 Company Overview
7.8 Geistlich Pharma AG (The Geistlich Group)
7.8.1 Company Overview
7.8.2 Recent strategies and developments:
7.8.2.1 Acquisition and Mergers:
7.9 Collagen Matrix, Inc. (Linden Capital Partners)
7.9.1 Company Overview
7.10. Dentium Co., Ltd
7.10.1 Company Overview
Companies Mentioned
- Medtronic PLC
- Zimmer Biomet Holdings, Inc.
- Dentsply Sirona, Inc.
- Stryker Corporation
- Institut Straumann AG
- BioHorizons, Inc. (Henry Schein, Inc.)
- RTI Surgical, Inc.
- Geistlich Pharma AG (The Geistlich Group)
- Collagen Matrix, Inc. (Linden Capital Partners)
- Dentium Co., Ltd.
Methodology
LOADING...
